ARDM Insider Trading Activity and SEC Form 4 Filings
ARDM insider trading summary
No open-market insider purchases or sales of Aradigm Corp (ARDM) have been reported on SEC Form 4 in the past 12 months.
Latest ARDM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 19, 2018 | Juergen Kurt Froehlich | Chief Medical Officer | Sell | $367 (306 @ $1.20) |
| Jan 29, 2018 | Juergen Kurt Froehlich | Chief Medical Officer | Sell | $26K (17,011 @ $1.53) |
| Apr 4, 2017 | Juergen Kurt Froehlich | Chief Medical Officer | Sell | $6K (3,765 @ $1.51) |
| Oct 4, 2016 | Juergen Kurt Froehlich | Chief Medical Officer | Sell | $3K (423 @ $6.76) |
| Jun 21, 2016 | Juergen Kurt Froehlich | Chief Medical Officer | Sell | $1K (333 @ $4.45) |
| Dec 13, 2013 | Virgil Thompson | Director | Sell | $568 (3,340 @ $0.17) |
| Aug 27, 2013 | First Eagle Investment Management, LLC | 10% Owner | Buy | $5.0M (40,322,580 @ $0.12) |
| Aug 27, 2013 | First Eagle Value in Biotechnology Master Fund, Ltd. | 10% Owner | Buy | $5.0M (40,322,580 @ $0.12) |
| Aug 27, 2013 | 21 April Fund Ltd | 10% Owner | Buy | $5.0M (40,322,580 @ $0.12) |
| Aug 27, 2013 | 21 April Fund LP | 10% Owner | Buy | $5.0M (40,322,580 @ $0.12) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.